‘Treatment No Less Favorable’ and the Future of National Treatment Obligation in GATT Article III:4 After EC–Seal Products

World Trade Review - United Kingdom
doi 10.1017/s1474745615000245
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Assessment of Self-Assembling Peptide P 11-4 in the Treatment of White Spot Lesions After Orthodontic Treatment

Egyptian Orthodontic Journal
2020English

The Harrison Law a National Obligation

JAMA - Journal of the American Medical Association
Medicine
1915English

Static Respiratory Compliance in the Newborn. III: Early Changes After Exogenous Surfactant Treatment.

Archives of Disease in Childhood: Fetal and Neonatal Edition
PediatricsGynecologyPerinatologyObstetricsMedicineChild Health
1994English

Autolysed Yeast Products in the Treatment of Anaemia

BMJ
1933English

Review Article: Systemic Treatment of Hepatocellular Carcinoma

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

The Future of Alzheimer's Disease Treatment

Aging Health
2006English

Future Trends in the Treatment of Atopic Dermatitis

Immunological Medicine
AllergyImmunology
2019English

More Criticism-Article on Neurodevelopmental Treatment

American Journal of Occupational Therapy
MedicineOccupational Therapy
1983English

GATT Standards Code Activities of the National Institute of Standards and Technology - 1990

1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy